Trials / Completed
CompletedNCT04284813
Families With Substance Use and Psychosis: A Pilot Study
Treatment Engagement in Families With Substance Use and Psychosis: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Mclean Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop and evaluate an intervention that adapts Community Reinforcement and Family Training (CRAFT) for families experiencing first episode psychosis and substance use delivered via telemedicine (video conferencing). The intervention aims to improve treatment engagement and reduce distress, and it will be delivered via telemedicine (CRAFT-FT). To assess feasibility of the intervention, family members will complete the sessions and provide feedback to refine the treatment manual. Data on client relatives with psychosis will be collected for preliminary assessment purposes. Client relatives will not complete the research study intervention.
Conditions
- Psychosis
- Substance Use
- Substance Use Disorders
- Family
- Tobacco Use
- Nicotine Use Disorder
- Cigarette Smoking
- Cannabis
- Marijuana
- Alcohol Use Disorder
- Alcohol
- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder
- Mental Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | CRAFT-FT | CRAFT-FT will be delivered via telemedicine. Topics include building motivation, self-care, communication, understanding patterns of behavior, positive reinforcement, and negative consequences. The intervention will be tailored to families of individuals experiencing psychosis and substance use who are enrolled in first episode psychosis outpatient services. Participants will be asked to completed assessments at pre-treatment, mid-treatment (approximately week 3), post-treatment, and a follow-up assessment approximately 3 month post-treatment. |
Timeline
- Start date
- 2020-09-24
- Primary completion
- 2021-08-25
- Completion
- 2022-07-07
- First posted
- 2020-02-26
- Last updated
- 2022-10-12
- Results posted
- 2022-10-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04284813. Inclusion in this directory is not an endorsement.